Delivery Order SPE2DB22D2007-SPE2DB24FJ4GR
Award Date
7/17/24
Potential Completion Date
8/7/24
Potential Value
$18K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $19,131.12, is for the delivery of ZEPZELCA 4 MG VIALS. It is a firm fixed-price delivery order contract with an ultimate completion date of April 29, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $95,655.40 firm fixed-price delivery order contract is for the provision of ZEPZELCA 4 MG VIALS, a specialty pharmaceutical product. The contract has an ultimate completion date of February 3, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of ZEPZELCA 4 MG VIALS, a pharmaceutical product, with a ceiling value of $9,565.56 and a period of performance through June 25, 2025. The contract is a firm fixed-price arrangement and does not utilize a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a for-profit organization that...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation for the supply of ZEPZELCA 4 MG VIALS. The contract is a Firm Fixed Price type with a ceiling value of $9,025.76 and a period of performance through September 4, 2024. The contract was awarded on August 13, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, is the prime contractor for this delivery order. This...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of ZEPZELCA 4 MG VIALS. The fixed-price, firm-fixed-price contract has a ceiling value of $18,675.40 and an ultimate completion date of January 9, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,675.40 Firm Fixed Price Delivery Order contract is for the provision of ZEPZELCA 4 MG VIALS, a specialty cancer medication. The contract has an ultimate completion date of December 31, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of Zepzelca 4 mg vials, a specialty medication. The contract has a ceiling value of $28,696.68 and a period of performance through February 20, 2025. The contract is a firm fixed-price arrangement with no set-aside designation, indicating open competition. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor and has an extensive Indefinite...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of ZEPZELCA 4 MG VIALS. The $9,025.76 firm-fixed-price delivery order has a completion date of November 26, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a wide range of pharmaceutical...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,565.56 contract is for the delivery of 4568517846 ZEPZELCA 4 MG VIALS, with a performance period through July 3, 2025. AmerisourceBergen Drug Corp is a for-profit organization that serves as a critical supplier of medical and pharmaceutical products to federal agencies, particularly the DLA, through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,337.72 firm-fixed-price delivery order is for the supply of ZEPZELCA 4 MG VIALS, a specialized pharmaceutical product. The contract has an ultimate completion date of December 31, 2024 and was awarded on December 9, 2024. No set-aside designation was used for this award. AmerisourceBergen holds a significant...